Cutler Group’s Intersect ENT, Inc XENT Stock Holding History

Cutler Group’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,600	Closed	-$3K	–	6576
2020 Q4	$3K	Buy	+1,600	New	+$30.5K	﹤0.01%	4068
2020 Q1	–	Sell	-24,000	Closed	-$130K	–	4904
2019 Q4	$130K	Buy	24,000 +16,000	+200%	+$324K	0.01%	1060
2019 Q3	$2K	Sell	8,000 -15,800	-66%	-$288K	﹤0.01%	3611
2019 Q2	$9K	Sell	23,800 -11,600	-33%	-$313K	﹤0.01%	2793
2019 Q1	$132K	Buy	+35,400	New	+$1.1M	0.01%	852
2017 Q3	–	Sell	-1,500	Closed	-$22K	–	7022
2017 Q2	$22K	Buy	+1,500	New	+$34K	﹤0.01%	3342
2016 Q4	–	Sell	-1,900	Closed	-$4K	–	7590
2016 Q3	$4K	Buy	+1,900	New	+$28.6K	﹤0.01%	5235

Other funds holding XENT

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Cutler Group's XENT Position: Q2 2021 in Review

Cutler Group sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 9,400 shares — an estimated $196K sold.

Cutler Group first reported a position in XENT in Q4 2015 and held it in 13 quarters. The position peaked at $505K in Q4 2019. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.

Cutler Group reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
Cutler Group sold 9,400 Intersect ENT, Inc shares in Q2 2021, an estimated $196K.
Cutler Group first reported a position in Intersect ENT, Inc in Q4 2015 and held it in 13 quarters.
Cutler Group's Intersect ENT, Inc position peaked at $505K in Q4 2019.
107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.